News provided by Resbiotic Nutrition, Inc
The Most Effective Delivery
With a growing percentage of the population using these drugs, there is a pressing need for more phase 4 clinical trials to understand their full impact on health and behavior
This monitoring should include blood chemistries, vital signs, plasma carnitine concentrations (the plasma free carnitine concentration should be between 35 and 60 mol/L) and overall clinical condition
The effect of DPP-4 inhibitors, GLP-1 receptor agonists and SGLT-2 inhibitors on cardiorenal outcomes: a network meta-analysis of 23 CVOTs
The Link Between GLP-1 Agonists and Gallstone Formation Emerging evidence suggests a potential association between GLP-1 receptor agonist therapy and an increased incidence of gallbladder-related complications, including cholesterol gallstone formation and acute cholecystitis